Skip to content

Public FDA record

Z-0818-04: ARCHTECT System RS-232 Manual, product list number 06F71-04, for the ARCHITECT i2000 Processing Module an

Recall record Z-0818-04 for Abbott Laboratories, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0818-04
Company in FDA record
Abbott Laboratories, Inc
FDA classification date
Jul 20, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

When using a LIS the software system will send up a test result of up to 20 characters although the field is set to display only 15 characters per the RS-232 Manual.

Source facts

Action
Customers were notified by letter on March 23, 2004 to contact their LIS vendor and to reconfigure the ASTM Field 10.1.4 to allow a maximum character length of 20 characters.
Initiated
2004-03-19
Root cause
Other
Terminated
2005-11-03
Distribution
Nationwide and to the following foreign countries: Chile, Canada, Germany, Taiwan, Australia, Signapore
Recall number
Z-0818-04
Recall status
Terminated
CDRH record ID
32420
FDA classified
2004-07-20
Recall event number
28728

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗